A Prospective Feasibility Study Using ctDNA to Tailor Neoadjuvant Chemotherapy for Patients With Colorectal or Appendiceal Adenocarcinoma

NCT05947838 · clinicaltrials.gov ↗

NA

Phase

RECRUITING

Status

48

Enrollment

OTHER

Sponsor class

Conditions

Appendiceal Adenocarcinoma
Colorectal

Interventions

PROCEDURE: Circulating tumoral DNA directed neoadjuvant therapy arm

Sponsor

M.D. Anderson Cancer Center